Midazolam, dexmedetomidine or ketamine: which of these used intranasally as premedication has better outcomes in childer undergoing brain MRI
Not Applicable
- Conditions
- Health Condition 1: G80-G83- Cerebral palsy and other paralytic syndromes
- Registration Number
- CTRI/2018/11/016366
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA-PS 1 &2
Exclusion Criteria
patients below 1 year of age
patients above 6 years of age
parents refusal to participate in the study
ASA-PS 3 and above
any congenital heart disease
on beta blocker or digoxin therapy
any implants incompatible with MRI
patient requiring emergency MRI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO COMPARE THE EFFECT OF INTRANASAL DEXMEDITOMIDINE, MIDAZOLAM AND KETAMINE IN PARENT-CHILD SEPARATION SCORETimepoint: 30 minutes
- Secondary Outcome Measures
Name Time Method 1. TO COMPARE THE EFFECT OF INTRANASAL DEXMEDITOMIDINE, MIDAZOLAM, KETAMINE IN SEDATION OF THE CHILD BY OBSERVER ASSESSMENT SCORE. <br/ ><br>2. TO LOOK FOR ANY SIDE EFFECTS OF THE STUDY DRUG.Timepoint: 6 hours